Stallergenes Greer, a global leader in allergy therapeutics, announced today that its Phase IIIb clinical study (YOBI, YOung patients and BIrch allergy), designed to confirm the safety and efficacy of ...
Immix Biopharma reported successful dosing of six patients in its Phase 1b trial for the CAR-T therapy NXC-201. The press release acknowledges that no drugs are currently FDA approved for patients ...
A study has developed a reliable way to measure whether seriously ill hospitalized patients receive medical care that aligns with their personal goals. The research, involving 109 seriously ill ...
Glucotrack, Inc. has announced the successful completion of its first human clinical study for a continuous blood glucose monitor (CBGM), which is uniquely placed in the subclavian vein for real-time ...
LOS ALTOS, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics (UNCY), Inc. , a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” ...
n = number of patients included in each study group for safety and tolerability assessments Abbreviations: EOS: End of Study (week 16); BID: twice daily; CBD: cannabidiol; QD: once daily. Of the DHT ...
isixsigma on MSN
Mastering Gage R&R: Key Steps for a Successful Study
Gage R&R is all about the integrity of your measurement system and its ability to capture the true values of what you are ...
Want to have successful IVF? If you're an older woman, find some donor eggs. Most successful fertility treatments for women 43 and older rely on donor eggs, researchers report in the journal ...
Stallergenes Greer, a global leader in allergy therapeutics, announced today that its Phase IIIb clinical study (YOBI, YOung patients and BIrch allergy), designed to confirm the safety and efficacy of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results